There are certain testing requirements that must be followed depending on the type of storage you will be using. Find the section that applies to you for a full list of these requirements.
Standard embryo storage fees are assessed when both client depositors (or gamete donors) have completed and are non-reactive for at least Anti-HIV 1 & 2 (AIDS) testing. Embryos will be accepted without Anti-HIV 1 & 2 (AIDS) or reactive testing and will be assessed Potentially Infectious storage fees.
We will accept embryos from patients who have tested reactive for one or more of the following: Anti-HIV 1 & 2, Hepatitis C – HCV, HTLV I & II, and Hepatitis B – HBsAg. Potentially Infectious storage fees will be assessed.
Embryos created with donor eggs or donor sperm will require additional testing and screening per FDA guidance.
Standards and/or Regulations require that patients complete the following serology/virology testing prior to release of embryos from storage with ReproTech for transfer back to a patient’s clinic for use: Hepatitis B – HBsAg, and Hepatitis C – Anti-HCV, in addition to Anti-HIV 1 & 2.
Standard storage fees are assessed for individuals (or gamete donors) who have completed and are non-reactive for at least Anti-HIV 1 & 2 (AIDS) testing. Sperm or Testicular Tissue specimens will be accepted without Anti-HIV 1 & 2 (AIDS) or reactive testing at Potentially Infectious storage fees.
We will accept semen or tissue specimens from patients who have tested reactive for one or more of the following: Anti-HIV 1 & 2, Hepatitis C – HCV, HTLV I & II, and Hepatitis B – HBsAg. Potentially Infectious storage fees will be assessed.
Donor specimens require additional testing and screening per FDA guidance.
Standards and/or Regulations require that patients complete the following serology/virology testing prior to release of embryos from storage with ReproTech for transfer back to a patient’s clinic for use: Hepatitis B – HBsAg, and Hepatitis C – Anti-HCV, in addition to Anti-HIV 1 & 2.
Standard storage fees are assessed when the client depositor has completed and is non-reactive for at least Anti-HIV 1 & 2 (AIDS) testing. Oocytes or Ovarian Tissue will be accepted without Anti-HIV 1 & 2 (AIDS) or reactive testing and will be assessed Potentially Infectious storage fees.
We will accept oocytes or tissue from patients who have tested reactive for one or more of the following: Anti-HIV 1 & 2, Hepatitis C – HCV, HTLV I & II, and Hepatitis B – HBsAg. Potentially Infectious storage fees will be assessed.
Donor oocytes require additional testing and screening per FDA guidance.
Standards and/or Regulations require that patients complete the following serology/virology testing prior to release of specimens from ReproTech for transfer back to a patient’s clinic for use: Hepatitis B – HBsAg, and Hepatitis C – Anti-HCV, in addition to Anti-HIV 1 & 2.
